6e thear.quinlancolwell determining if poss is safe i ... conference documents... · fracture...

24
1 Use of the Pasero Opioid-Induced Sedation Scale in Pediatric Patients Emily Miller –Baldwin BSN Andrea Smith BSN Gayle Thear MSN Ann Quinlan-Colwell PhD Conflict of Interest Disclosure Authors Conflicts of Interest: E. Miller-Baldwin, No Conflict of Interest A. Smith, No Conflict of Interest G. Thear, No Conflict of Interest A. Quinlan-Colwell, Consultant & Speaker for Mallinckrodt Non-branded Education NHRMC PEDIATRICS

Upload: vuongdien

Post on 24-Jul-2018

213 views

Category:

Documents


0 download

TRANSCRIPT

1

Use of the Pasero Opioid-Induced Sedation Scale in Pediatric Patients

Emily Miller –Baldwin BSNAndrea Smith BSNGayle Thear MSNAnn Quinlan-Colwell PhD

Conflict of Interest Disclosure

• Authors Conflicts of Interest:

– E. Miller-Baldwin, No Conflict of Interest

– A. Smith, No Conflict of Interest

– G. Thear, No Conflict of Interest

– A. Quinlan-Colwell, Consultant & Speaker for

– Mallinckrodt Non-branded Education

NHRMC PEDIATRICS

2

Introduction

• The Pasero Opioid‐Induced Sedation scale

(POSS) is a valid and reliable  tool that is  used 

to assess sedation during opioid pain management.

• Although the POSS has been used in Pediatric patients at some hospitals it has never been formally evaluated in the pediatric population.

Pasero Opioid-Induced Sedation Scale (POSS)

Purpose

• This study was designed to compare the use

of the POSS during opioid administration 

before and after implementation of 

a standardized POSS protocol in pediatric patients.

• In addition, a self reporting survey of the pediatric nurses caring for the subjects was used to determine ease of use andappropriateness.

3

Background

• Pediatric patients can be especially vulnerable to respiratory depression during the administration of opioids for analgesic purposes, thus these patients require close monitoring. 

Background

• A tool such as the POSS, can be used to:• Assess sedation

• Identify progressing sedation early

• Improve communication

• Recognition of trends

• Confidence in treatment

METHOD

• IRB approval was obtained

• Consent obtained:

– Intervention cohort 

– Nursing surveys

• Control cohort did not require consent

4

METHOD: Literature Search

• Databases used:

– CINHAL, Pub Med, Google Scholar, Joanna Briggs

• Key words:

– opioids, analgesic sedation, Pasero, POSS

• From these databases:

– 14 articles were retained and used

METHOD: Setting

• Setting

• New Hanover Regional Medical Center

– 23 bed pediatric unit

– including a 6 bed ICU

• A convenience sample was used

Pediatric Treatment Room

5

Pediatric Patient Room

METHOD: Sample

• Sample Size

• Intervention cohort:

– 27 participants and 362 doses

• Control cohort:

– 25 participants and 363 doses

• Nursing surveys:

– 19 completed

METHOD: Sample

• Pediatric Intervention Cohort:

• 38 potential participants

– Excluded 8

• 1 meninges disorder, 1 malignant neoplasm (head), 2 head injuries, 1 trisomy 21, 1 stabbing, 2 received no opioid doses

– Missed consents 2

– Refusal 1

– Consented and data collected 27

6

METHOD: Sample

Pediatric Control Cohort:

• Excel spreadsheet

• Data obtained from medical records that included criteria– 25 participants

METHOD: Design

• A quasi-experimental design

• Data collected from medical records

of both cohorts to determine:

– Incidence of respiratory depression

– Comparison of RN documentation of sedation:• prior to implementation of standardized POSS assessment

• after implementation of standardized POSS assessment

METHOD: Design

• Education provided to pediatric RN’s

about the Pasero Opioid-Induced

Sedation Scale prior to research being

started.

• Team informed pediatric RN’s of the research being conducted.

• Evaluate RN’s impression on use of POSS

• Nursing survey was completed by pediatric RN’s if interested inparticipating in study

7

METHOD: Data Points

• Data points for both intervention and

control cohort:• gender, age, opioid dose, pain score,

• held dose, decrease/increase dose

• level of alertness

• respiratory rate– prior to dose

– after each dose

• Additional data for the intervention cohort includedPOSS score

METHOD: Pediatric Intervention Cohort

• Daily monitoring of census

• Potential participants screened

• Consent was then obtained from parent/legal guardian

METHOD: Pediatric Intervention Cohort

• Participant number assigned– Sequential order

– Separate master list– Secure spreadsheet on PI computer only

• Data collection initiated– Given to PI for transcribing to secure spreadsheet

– Collected until:• targeted number of opioid doses reached

• or 11 months of data collection

8

METHOD: Pediatric Control Cohort

• Medical records department sent PI data

from past pediatric patients that fit

inclusion criteria

• Restricted range of time for data collection:– 01/01/2013 to 12/31/2013

• Data obtained from medical record– given to the PI for transcription and secure storage

METHOD: Inclusion Criteria

• Intervention cohort:– Current pediatric patients receiving

opioids for analgesic purposes

– Diagnosis of at least one of the following:appendectomy HSV

migraine appendicitis

Fracture herpangina

hand foot and mouth disease

METHOD: Inclusion Criteria

• Control cohort:– Former pediatric patients receiving opioids for analgesic

purposes

– Admitted from 01/01/2013 through 12/31/2013

– With at least one diagnosis that met criteria

9

METHOD: Exclusion Criteria

• Intervention and control cohort:– Diagnosis of respiratory distress

– Head injuries

• Additional control cohort exclusion:– Any patient in which POSS score was already documented

METHOD: Nursing Survey

• Evaluate the appropriateness an ease of use

• Consisted of 10 questions related to POSS

• Voluntary and implied the RN’s consent

– 25 possible

– 19 completed and returned

• Completed surveys were placed in sealed envelope and keptin a sealed box, ensuring anonymity.

Pediatric Play Room

10

Pediatric Play Room

DATA ANALYSIS

• Control cohort data consisted of

– 25 participants

– 363 doses

• The data was extracted from medical records based ondiagnosis and inclusion criteria.

• Intervention cohort data consisted of

– 27 participants

– 362 doses

• A total of 19 nursing surveys were obtained

DATA ANALYSIS

• Data was analyzed using JMP 11.0 software.

• Any p-value <0.05 was considered statisticallysignificant

• Chi-Square was used to test differences betweencohorts and– the p-value for differences was <0.0001

11

Age

Gender Comparison of Subjects

CharacteristicStandardN = 25

POSSN = 27

P‐value

Gender

Male 12 (48.0) 13 (48.2) 0.9915

Female 13 (52.0) 14 (51.8)

Age 8.0 [4.0-13.0] 12.0 [8.0-16.0] 0.0156

12

13

DATA ANALYSIS

• SURVEY RESULTS

RNs response to survey questions:

supported the statistical finding from the data collected in the two cohorts

DATA ANALYSIS

Five Survey Questions

Had the

Strongest Correlations

Nursing Survey Demographics

• Question 1 – Years as a pediatric nurse

– n= 19 nurses

– Median =4 years, Mean =5.8 years

– Range 0.16 to 25

• Question 2‐ Used the POSS on one or more patients

– Yes=17

– No=1

– Non‐response= 1

• The two participants who answered no and non‐responseanswered neutral for all the other questions

14

Survey Responses Questions 3&4

I feel confident I have used the POSS correctly

Every patient on opioids for analgesic purposes should be

scored by the POSS.

Survey Responses Questions 5&6

Using the POSS to score pediatric patient sedation levels was easy.

I feel confident I have scored the pediatric patient’s sedation level correctly when using the

POSS.

The POSS helped with continuity of the assessment and charting on my

pediatric patient’s sedation level while on opioids for pain control.

*1 missing value

Survey Responses Questions 7&8

The POSS helped me respond appropriately to the patient’s

clinical changes

15

Survey Responses Questions 9 & 10

I found the POSS to be an appropriate scale to use for pediatric patients receiving

opioids for analgesic purposes

The POSS helped to standardize a safe use of opioids when

administered for pain

DATA ANALYSIS

• Question  9 

– “POSS is an appropriate scale to use on

pediatric patients”

• Question 10 

– “POSS helped to standardize the safe use of opioids”

– (r=0.87, p=<.05)

• Nurses who believed the POSS was an appropriate scale forpediatric patients were more likely to:

– Agree the POSS helped standardize the safe use of opioids

DATA ANALYSIS

• Question 3– “Confident they used POSS correctly”

• Question 7– “POSS helped with continuity of assessment and charting”

– (r=0.84, p=<.05)

• Nurses who were confident they used POSS correctly werealso more likely to:

– Agree POSS helped with the continuity of assessment andcharting sedation levels

16

DATA ANALYSIS

• Question 5– “The POSS was easy to use”

• Question 6– “ Confident that the sedation level was correct using the

POSS”

– (r=0.81, p=<.05)

• Nurses who felt the POSS was easy to use were also morelikely to:

– Feel confident they scored the patient sedation correctly

DATA ANALYSIS

• Question 6– “ Confident that the sedation level was

correct using POSS”

• Question 10– “POSS helped to standardize the safe use of opioids”

– (r=0.78,p=<.05)

• Nurses who believed they scored patient sedationcorrectly with POSS were also more likely to:– Agree the POSS helped standardize the safe use of

opioids

Correlation MatrixNumber of

years a pediatric

nurse

3 confident used POSS

correctly

4 every pt on opioids should be scored by

POSS

5 using POSS was easy

6 confident that sedation level was

correct using POSS

7 POSS helped w continuity of

assessment & charting

8 POSS helped to respond to clinical

changes

9 POSS is appropriate scale

for peds pt

10 POSS helped to standardize safe us of

opioids

Number of years a pediatric nurse

1.000 -0.0246 -0.3609 -0.793 -0.716 -0.3395 -0.3492 -0.5228 -0.6545(p<.05) (p<.05) (p<.05) (p<.05)

3 confident used POSS correctly

1.000 0.2712 0.4014 0.318 0.8439 0.7346 0.4083 0.4187(p<.05) (p<.05)

4 every pt on opioidsshould be scored by POSS

1.000 0.3504 0.3315 0.3599 0.1973 0.6119 0.4599

(p<.05) (p<.05)

5 using POSS was easy

1.000 0.8081 0.6396 0.5282 0.6689 0.7687

(p<.05) (p<.05) (p<.05) (p<.05) (p<.05)6 confident that sedation level was correct using POSS

1.000 0.4449 0.5449 0.5833 0.7796(p<.05) (p<.05) (p<.05)

7 POSS helped w continuity of assessment & charting

1.000 0.779 0.6075 0.5369

(p<.05) (p<.05) (p<.05)

8 POSS helped to respond to clinical changes

1.000 0.4358 0.6318

(p<.05)9 POSS is appropriate scale for peds pt

1.000 0.8662

(p<.05)10 POSS helped to standardize safe us of opioids

1.000

17

Pediatric Play Room

Pediatric Play Room

DISCUSSION

General consensus 

from RN’s survey was 

that the POSS: 

‐ was easy to use 

‐ appropriate for pediatric patients

18

DISCUSSION

Data extracted from the medical records 

for the control cohorts revealed that prior

to POSS,  RNs annotated vague word descriptors 

to document alertness or sedation such as:

crying, 

resting, 

awake, drowsy, 

sleeping, watching TV and 

resting with eyes closed.

POSS

Discussion

There was an improvement in documentation

with the use of the POSS

• RNs were able to standardize the assessment of patients receiving opioids for analgesic purposes through the use ofthe POSS 

• Using a scale like the POSS has standardized description andactions for each level of sedation 

19

Discussion

POSS

isReliable

Valid Tool

In the Pediatric Population 

over one year of age

Discussion

RNs confidence level 

improved 

with the use of the POSS

Discussion

Improving RN communication 

regarding sedation 

ultimately 

improves patient safety

20

LIMITATIONS

• A relatively small sample size

• The sample was convenient and not randomized

• There were more opioid administrations in older subjects inthe intervention group than the control group

LIMITATIONS

It was not a blind study therefore the potential for bias existed as the staff knew the data was being collected

IMPLICATIONS FOR PRACTICE AND RESEARCH

• Follow up plans to improve compliance with assessment anddocumentation of the POSS need to be implemented

• Nurses should be surveyed again to compare currentperceptions with original survey perceptions

21

IMPLICATIONS FOR PRACTICE AND RESEARCH

• Tool for:– Improved communication with parents

– patient and family education (safe pain control)

IMPLICATIONS FOR PRACTICE AND RESEARCH

• The study should be replicated

– using a randomized control design

– in a larger sample of pediatric patients

• As this study did not include any participants under 1 year ofage, additional study of the use of POSS in infants younger than 1 year is also warranted 

CONCLUSION

• The tool gives standardized information regarding how awake or sedated a pediatric patient is prior to and after administering an opioid

• This will optimize safe and effective analgesia to pediatric patients

22

Conclusion

• The POSS will also provide consistent language that facilitatescommunication about sedation among the healthcare providers

• The POSS is a reliable tool for opioid sedation assessment inpediatric patients between ages 1‐17 years old.

Research to Practice

• This research project was an opportunity to take what began as a question posed by the pediatric practice council, throughthe research process, and into practice at the bedside.

We would like to acknowledge

the participation of:

Lacy Aycock, RN, FNPHugh Crews, PhD

23

REFERENCES

• Carstens, J. (2011). Sedation (pediatric): Diagnostic and therapeuticprocedures [ Evidence Summary]. Retrieved from Joanna Briggs Institute Evidence Based Practice Website. http://joannabriggslibrary.org/

• Dempsey, S.J. (2012). Use of the Pasero Opioid-induced Sedation Scale to reduce oversedation. Niche Solutions. http://www.nicheprogram.org/niche_solutions_series

• Friedrichsdorf, S. J., & Postier, A. (2014). Management of breakthrough pain in children with cancer. Journal of Pain Research, 117-123.

• Jarzyna, D., Jungquist, C. R., Pasero, C., Willens, J. S., Nisbet, A., Oakes, L., Dempsey, S. J., ... Polomano, R. C. (2011). American society for pain management nursing guidelines on monitoring for opioid-induced sedation and respiratory depression. Pain Management Nursing, 12(3), 118-145. doi: 10.1016/j.pmn.2011.06.008

REFERENCES

• Joint Commission (2012) The Joint Commission Sentinel Event Alert: Safe use of Opioids in hospitals , 49 August 8,2012 http://www.jointcommission.org/assets/1/18/SEA_49_opioids_8_2_12_final.pfd

• Jungquist, C.R., Karan, S., Perlis, M.L. (2011). Risk factors for opioid-induced excessive respiratory depression. Pain Management Nursing, 12(3), 180-187.

• Kobelt, P., Burke, K., & Renker, P. (2014). Evaluation of a standardized sedation assessment for opioid administration in the post anesthesiacare unit. Pain Management Nursing, 15(3), 672-681. doi: 10.1016/j.pmn.2013.11.002

• Martin, D.P., Bhalla, T., Beltran, R., Veneziano, G., & Tobias, J. D. (2014). The safety of prescribing opioids in pediatrics. Expert Opinion Informa Healthcare, 13(1), 93-101. doi: 10.1517/14740338.2013.8340

References

• Nisbet, A. T., & Mooney-Cotter, F. (2009). Selected sedation scales

• for reporting opioid-induced sedation assessments: Validity, reliability, ease of use, clinical decision making, and nursing confidence. Pain Management Nursing. 10(3), 154-164. doi: 10.1016/j.pmn.2009.03.001

• Pasero, C. (2009). Assessment of sedation during opioid administration for pain management. Journal of PeriAnesthesia Nursing, 24(2), 186-190. doi: 10,1016/j.jopan.2009.03.005

• Pasero, C. (2012). Opioid-induced sedation and respiratory depression: Evidence-based monitoring guidelines. Journal of PeriAnesthesia Nursing, 27(3), 208-211. doi: 10.1016/j.jopan.2012.03.003

24

REFERENCES

• Pasero, C., & McCaffery, M. (, 2002). Monitoring sedation:It’s the key to preventing opioid -induced respiratorydepression. American Journal of Nursing, 102(2), 67-69.

• Quinlan-Colwell, A. (2013, April). A tool to assess sedation,and so much more. SPS News, 1-8.

• Smith, A., Farrington, M., Matthews, G. (2014). Monitoringsedation in patients receiving opioids for pain management.Journal of Nursing Care Quality, 29(4), 345-353.

Thank You

QUESTIONS or COMMENTS?